The National Organization for the Reform of Marijuana Laws Political Action Committee (NORML PAC) has announced their most recent slate of bi-partisan reelection endorsements for incumbent members of the United States House of Representatives.
In advance of NORML’s 2018 Conference and Lobby day that’s taking place July 22nd – 24th in Washington, DC, NORML chapters from around the country are organizing grassroots letter writing campaigns targeting members of the House and Senate requesting their immediate support of pending marijuana-related legislation.
Welcome to the latest edition of NORML’s Weekly Legislative Roundup!
Lawmakers on both sides of the aisle strongly rejected a recent move by Attorney General Jeff Sessions to crackdown on states that have legalized marijuana.
NORML Chapters across the country are starting to shift their focus from state-level lobbying efforts to Congressional Town Hall meetings for the August recess. In addition to engaging their representatives, activists will be encouraging participants to join the marijuana law reform conversation.
Spending legislation approved in the past 24 hours by members of the US House and Senate reauthorizes language protecting state-sanctioned medical marijuana and industrial hemp programs through this fall.
Today is the final day that Congress has to pass a short-term budget to fund the federal government and it’s up to us to make sure that lawmakers reauthorize the Rohrabacher-Farr amendment. This critical amendment stops Jeff Sessions’ Department of Justice from targeting state-sanctioned medical marijuana patients, growers, caregivers, and providers.
This 4/20, tell your elected officials it is time for the Congress to respect the will of the majority of American citizens and end federal marijuana prohibition.
If the Justice Department won’t listen to reason, then we must take this issue out of its hands. Act now to pass the “Ending Marijuana Prohibition Act of 2017” to ensure that medical marijuana patients and others are protected from undue federal interference.
Members of Congress have re-authorized a federal provision prohibiting the Justice Department from interfering in state-authorized medical cannabis programs. The provision, known as the Rohrabacher-Farr amendment, was included in short-term spending legislation, House Resolution 2028, and will expire on April 28, 2017. NORML is encouraging you to tell the incoming Congress that these pivotal patient protections must remain included in any future federal spending bills.